Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KROS
#2419
Keros Therapeutics, Inc. Common Stock
14.190
0
-3.14%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-3.14%
Mudança mensal
-21.86%
Mudança em 6 meses
-6.03%
Mudança anual
-6.03%
Fechamento anterior
14.650
0
Open
14.190
0
Bid
Ask
Low
14.190
0
High
14.190
0
Volume
60
Mercados
Ações
Cuidados de saúde
KROS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
40.51 M
40.56 M
40.62 M
40.62 M
30.47 M
—
Valuation ratios
Enterprise value
1.82 B
82.2 M
-306.67 M
-148 M
-211.5 M
-583.97 M
Price to earnings ratio
-11.15
-3.17
-59.94
41.72
10.21
-11.18
Price to sales ratio
3 134.08
166.94
1.94
2.35
2.63
173.86
Price to cash flow ratio
14.42
3.68
1.44
2.55
3.51
11.18
Price to book ratio
1.17
1.04
0.17
0.21
0.23
1.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.07
0.19
0.04
0.01
0.31
Return on equity %
0.1
0.08
0.2
0.04
0.01
0.34
Return on invested capital %
—
710.18
1 604.14
361.25
139.94
2 815.51
Gross margin %
100
100
100
100
100
400
Operating margin %
15.12 K
1 750.62
71.99
219.16
108.92
2 150.7
EBITDA margin %
—
—
—
—
—
—
Net margin %
13.65 K
1 513.02
70.29
168.96
51.54
1 803.81
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
19.03
21.45
19.29
21.11
29.86
91.71
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.3
0.02
0.02
0.35
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.81
1.23
3.93
-0.73
0.08
4.51
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.12
14.96
17.57
16.99
17.07
66.59
Net current asset value per share
14.69
15.73
18.51
18.04
17.71
70
Tangible book value per share
14.17
15.27
17.77
17.4
17.32
67.76
Working capital per share
13.91
15
17.56
17.19
17.11
66.85
Book value per share
14.17
15.27
17.77
17.4
17.32
67.76
Notícias
Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?
Is KROS' KER-065 the Next Breakthrough in DMD Space?
JANX Enters Global Oncology Collaboration With BMY, Stock Rises
Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease
Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia
Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?
CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why